Skip to main content

. 1985 Oct;54(4):452–453. doi: 10.1136/hrt.54.4.452

Skin apolipoprotein B values in normocholesterolaemic patients with coronary artery disease: a discriminatory test.

P Douste-Blazy, J C Thiers, P Valdiguie, H Bouissou, J de Graeve, P Bernadet

PMCID: PMC481927 PMID: 4052286

452

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

De Graeve J., Bouissou H., Thiers J. C., Fouet J., Valdiguié P. Is cutaneous apoprotein B a better discriminator than serum lipoproteins for atherosclerosis? Atherosclerosis. 1984 Sep;52(3):301–307. doi: 10.1016/0021-9150(84)90060-1. [DOI] [PubMed] [Google Scholar]
Milne R. W., Douste-Blazy P., Marcel Y. L., Retegui L. Characterization of monoclonal antibodies against human apolipoprotein E. J Clin Invest. 1981 Jul;68(1):111–117. doi: 10.1172/JCI110225. [DOI] [PMC free article] [PubMed] [Google Scholar]
Sniderman A., Shapiro S., Marpole D., Skinner B., Teng B., Kwiterovich P. O., Jr Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins]. Proc Natl Acad Sci U S A. 1980 Jan;77(1):604–608. doi: 10.1073/pnas.77.1.604. [DOI] [PMC free article] [PubMed] [Google Scholar]
Wulfert E., Legendre C., Thiers J. C., de Graeve J., Solera M. L., Bouissou H. Determination of apoprotein B in the skin. Pathol Biol (Paris) 1984 Jan;32(1):70–72. [PubMed] [Google Scholar]

ACTIONS

RESOURCES